BPH management: New paradigms, new approaches

The paradigm for the medical management of benign prostatic hyperplasia has undergone a significant change during the past decade. Guided by new research, the approval of novel pharmaceutical and minimally invasive therapies, and the economics of health care financing, physicians have altered their approach to patient care in distinct ways.

Related Videos
© 2023 MJH Life Sciences

All rights reserved.